SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotime-Nasdaq's best kept secret?
BTIM 0.00010000.0%Nov 5 1:26 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: webster who wrote (1065)7/21/1998 10:05:00 PM
From: John L.  Read Replies (1) of 1432
 
I think the royalty is 36% if sales are above a certain level, $400 million @ 36% yields $144 million. With about 10 million shares and expenses for 11 employees, lets estimate $4 million, that leaves us with EPS of $14/share. This would sure be a nice number to see at the turn of the century, I bought this stock over 2 years ago with the hope of these kind of numbers. I will be a very happy investor if this happens or I will see my 1500 shares end up as toilet paper, there is no way I would bail on this stock at this time. FDA approval should send the price marching up, profits from Abbott sales this year or next should provide upward momentum and deals from Europe and Asia will put us over the top in my scenario. Still keeping the faith.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext